首页> 外文期刊>Therapeutic Drug Monitoring >Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure
【24h】

Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure

机译:克罗恩氏病活动指数或C反应蛋白与英夫利昔单抗的疾病呼吁对客观CROHN疾病活动措施进行缺乏关系,用于评估治疗效果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Circulating infliximab (IFX) concentrations correlate with clinical outcomes, forming the basis of the IFX concentration monitoring in patients with Crohn's disease. This study aims to investigate and refine the exposure-response relationship by linking the disease activity markers "Crohn's disease activity index" (CDAI) and C-reactive protein (CRP) to IFX exposure. In addition, we aim to explore the correlations between different disease markers and exposure metrics.
机译:背景:循环英夫利昔单抗(IFX)浓度与临床结果相关,形成克罗恩病患者IFX浓度监测的基础。 本研究旨在通过将疾病活性标志物“CROHN疾病活动指数”(CDAI)和C反应性蛋白(CRP)与IFX暴露联系起来,通过将疾病活性标记物“C-活性蛋白(CRP)联系起来,研究和优化暴露响应关系。 此外,我们的目标是探讨不同疾病标记和曝光度量之间的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号